Answers are grounded in this paper and cite their sources.
Analysis reveals distinct signaling networks in glioblastoma, suggesting links to cell cycle and plasticity.
Cancer cells, including the most aggressive brain cancer, glioblastoma, can exhibit a high degree of phenotypic plasticity. However, it is not well understood whether and how distinct phenotypic states might be associated with or driven by specific signaling processes. Here, we use a novel approach to the identification of phenotype-specific signaling networks in cells undergoing the Go-or-Grow switch in populations of GBM cell lines. We find that the transition to invasive spread may be associated with the onset of DNA damage response, cell cycle arrest, and activation of the AKT-mTOR signaling. We reconstructed the large-scale signaling networks, revealing integration of diverse pathways and possible feedback interactions mediating phenotypic stability. We further show that phosphorylation outcomes may be preferentially mediated by 14-3-3 proteins, previously implicated in stress response and control of the cell cycle. Finally, we demonstrate that the phenotype-specific phospho-site signatures have predictive power for disease-free patient survival. This study paves the way for a more comprehensive understanding of phenotypic plasticity in GBM and other aggressive cancers.
No takes yet. Share an insight, caveat, or question.
Khanal et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: